Costs of olanzapine treatment compared with haloperidol for schizophrenia: Results from a randomized clinical trial

被引：4
|
作者：
Hamilton, SH [1 ]
Revicki, DA [1 ]
Genduso, LA [1 ]
Tollefson, GD [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA RESEARCH | 1998年 / 29卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(97)88678-1
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 50 条
  • [41] Depressive signs and symptoms in schizophrenia: A prospective blinded trial of olanzapine and haloperidol
    Andersen, SW
    Tollefson, GD
    Sanger, TM
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 269 - 270
  • [42] An economic comparison of olanzapine versus haloperidol in the treatment of schizophrenia in France
    Gregor, KJ
    Allicar, MP
    Lilliu, H
    Bouhassira, M
    Le Pen, C
    SCHIZOPHRENIA RESEARCH, 2000, 41 (01) : 189 - 190
  • [43] Olanzapine versus haloperidol: Acute results of the multicenter international trial
    Tollefson, G
    Beasley, C
    Tran, P
    Dellva, MA
    Krueger, J
    Tamura, R
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 401 - 401
  • [44] A randomized, double-blind study of olanzapine vs haloperidol in the treatment of primary negative symptoms in schizophrenia
    Lindenmayer, J
    Iskander, A
    Abad, T
    Parker, B
    Lerman, M
    Khan, A
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 493 - 494
  • [45] Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: A double-blind, randomized controlled trial
    Wynn, Jonathan K.
    Green, Michael F.
    Sprock, Joyce
    Light, Gregory A.
    Widmark, Clifford
    Reist, Christopher
    Erhart, Stephen
    Marder, Stephen R.
    Mintz, Jim
    Braff, David L.
    SCHIZOPHRENIA RESEARCH, 2007, 95 (1-3) : 134 - 142
  • [46] Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania - Results from a randomized controlled trial
    Namjoshi, MA
    Rajamannar, G
    Jacobs, T
    Sanger, TM
    Risser, R
    Tohen, MF
    Breier, A
    Keck, PE
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 69 (1-3) : 109 - 118
  • [47] Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial
    Bhowmick, Subhrojyoti
    Hazra, Avijit
    Ghosh, Malati
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 (03) : 237 - 242
  • [48] Superior efficacy of olanzapine over haloperidol: Analysis of patients with schizophrenia from a multicenter international trial
    Gomez, JC
    Crawford, AMK
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 6 - 11
  • [49] Medical resource use and work and social outcomes for olanzapine compared with haloperidol in the treatment of schizophrenia and other psychotic disorders
    Hamilton, SH
    Genduso, LA
    Revicki, DA
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 148 - 149
  • [50] Is Flunarizine a Long-Acting Oral Atypical Antipsychotic? A Randomized Clinical Trial Versus Haloperidol for the Treatment of Schizophrenia
    Bisol, Luisa W.
    Brunstein, Miriam G.
    Ottoni, Gustavo L.
    Ramos, Fernanda L. P.
    Borba, Daniela L.
    Daltio, Claudiane S.
    de Oliveira, Ricardo V.
    Paz, Gisele E. G.
    de Souza, Sayuri E.
    Bressan, Rodrigo A.
    Lara, Diogo R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (10) : 1572 - 1579
12345